01:35 , Mar 9, 2019 |  BioCentury  |  Regulation

Gottlieb’s exit interview

FDA Commissioner Scott Gottlieb sat down with BioCentury after announcing his resignation to discuss his approach to promoting medical product innovation, the importance of strategic communications, and how a reorganization will bring FDA drug reviews...
20:49 , Feb 22, 2019 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least 12 profitable biotechs and pharmas are slated to report earnings this week. (A) Six-month EPS Company Date Pre/post mkt 4Q18 EPS est 4Q17 EPS Expected chg Corcept Therapeutics Inc. (NASDAQ:CORT)...
00:50 , Jan 5, 2019 |  BC Extra  |  Company News

Flurry of management moves on eve of JPM

More than 30 biopharma companies announced executive changes to kick off the New Year, including Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) and Immunocore Ltd. (Abingdon, U.K.), both of which brought on former AstraZeneca plc (LSE:AZN; NYSE:AZN) executives...
23:33 , Nov 2, 2018 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least nine profitable biotechs and pharmas are slated to report earnings this week. (A) Fiscal 1Q; (B) Fiscal 4Q Company Date Pre/post mkt 3Q18 EPS est 3Q17 EPS Expected chg Bausch...
21:35 , Aug 3, 2018 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least 8 profitable biotechs and pharmas are slated to report earnings this week. (A) Formerly Valeant Pharmaceuticals International Inc. Company Date Pre/post mkt 2Q18 EPS est 2Q17 EPS Expected chg Bausch...
23:21 , Jul 13, 2018 |  BioCentury  |  Finance

Pause for politics

The near record-setting pace of 1H18 capital markets activity isn’t likely to be replicated this half, but that won’t be because of changes to sector fundamentals. Instead, it’s likely the consequence of macroeconomic and geopolitical...
00:06 , May 5, 2018 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least 11 profitable biotechs and pharmas are slated to report earnings this week. (A) Fiscal 3Q; (B) 12-month EPS; Source: Yahoo! Finance, Financial Times, company websites Company Date Pre/post mkt 1Q18...
19:08 , Apr 20, 2018 |  BC Week In Review  |  Company News

Advent to acquire Sanofi's EU generics business

VC firm Advent International Corp. (Boston, Mass.) said it will acquire from Sanofi (Euronext:SAN; NYSE:SNY) the pharma's European generics business, Zentiva Group A/S, for €1.9 billion ($2.3 billion). Last year, Sanofi indicated it was looking...
19:24 , Apr 17, 2018 |  BC Extra  |  Company News

Advent to acquire Sanofi's European generics unit for €1.9B

VC firm Advent International Corp. (Boston, Mass.) said it will acquire from Sanofi (Euronext:SAN; NYSE:SNY) the pharma's European generics business, Zentiva Group A/S, for €1.9 billion ($2.3 billion). Last year, Sanofi indicated it was looking...
22:49 , Apr 3, 2018 |  BC Extra  |  Company News

Management tracks: Abeona, Dermavant, Assembly

Gene therapy play Abeona Therapeutics Inc. (NASDAQ:ABEO) said President and CEO Timothy Miller will transition to president and CSO. He is succeeded as CEO by Carsten Thiel, who was EVP and chief commercial officer at...